NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses

Montserrat García-Closas, Núria Malats, Debra Silverman, Mustafa Dosemeci, Manolis Kogevinas, David W. Hein, Adonina Tardón, Consol Serra, Alfredo Carrato, Reina García-Closas, Josep Lloreta, Gemma Castaño-Vinyals, Meredith Yeager, Robert Welch, Stephen Chanock, Nilanjan Chatterjee, Sholom Wacholder, Claudine Samanic, Montserrat Torà, Francisco FernándezFrancisco X. Real, Nathaniel Rothman

Research output: Contribution to journal › Article › peer-review

484 Scopus citations

Fingerprint

Dive into the research topics of 'NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses'. Together they form a unique fingerprint.

Medicine & Life Sciences